Concepedia

Analysis of the prognostic effects of inclusion in a clinical trial and of myelosuppression on survival after adjuvant chemotherapy for breast carcinoma

Catherine Mayers, Tony Panzarella, Ian F. Tannock

Cancer · 2001 · 12 citations · 13 references

DOIFull text

Open access

Concepts

Abstract

Treatment-related factors that might influence survival after adjuvant treatment for breast carcinoma include treatment as part of a clinical trial, toxicity of treatment, the regimen and schedule used, and dose intensity.

References

13

Regression Models and Life-Tables

D. R. Cox · Journal of the Royal Statistical Society Series B (Statistical Methodology) · 1972 · 39.3K citations · Full text

, , +16

Adjuvant Cyclophosphamide, Methotrexate, and Fluorouracil in Node-Positive Breast Cancer — The Results of 20 Years of Follow-up

G. Bonadonna, Pinuccia Valagussa, Angela Moliterni et al. · New England Journal of Medicine · 1995 · 1.1K citations

, , +17

Southwest Oncology Group standard response criteria, endpoint definitions and toxicity criteria

Stephanie Green, Geoffrey R. Weiss · Investigational New Drugs · 1992 · 616 citations

, , +14

Dose and Dose Intensity as Determinants of Outcome in the Adjuvant Treatment of Breast Cancer

Daniel R. Budman, Donald A. Berry, Constance Cirrincione et al. · JNCI Journal of the National Cancer Institute · 1998 · 582 citations

, , +17

Analysis of dose intensity for adjuvant chemotherapy trials in stage II breast cancer.

W M Hryniuk, M N Levine · Journal of Clinical Oncology · 1986 · 459 citations

, , +17